Hemp Health Spolka Akcyjna Logo

Hemp Health Spolka Akcyjna

A vertically integrated supplier of medical cannabis raw material for the Polish market.

HMP | WAR

Overview

Corporate Details

ISIN(s):
PLEBCSL00011 (+4 more)
LEI:
259400HT196UIMTSG008
Country:
Poland
Address:
WARSZAWA JANA STYKI 23, 03-928 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hemp & Health S.A. is a company operating at the intersection of the hemp and health sectors. The company's 2024-2025 strategy is centered on creating and managing a vertically integrated supply chain for medical marijuana. Its planned operations span from proprietary cultivation, importation, and processing to the final distribution of medical cannabis as a pharmaceutical raw material. The company's primary strategic objective is to establish itself as a leading Polish entity in the medical cannabis market, controlling the entire value chain to ensure quality and supply.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-05-10 10:55
M&A Activity
Rozpoczęcie negocjacji dotyczących nabycia przez Hemp_Health spółki z branży ma…
Polish 1.2 KB
2024-04-30 13:22
Share Issue/Capital Change
Przydział warrantów subskrypcyjnych serii B - Content (PL)
Polish 831 bytes
2024-04-23 20:47
M&A Activity
Zakończenie negocjacji opisanych w raporcie ESPI nr 5/2024 bez uzyskania porozu…
Polish 845 bytes
2024-04-22 12:22
Major Shareholding Notification
zal01_DC.22.04.2024.FormularzA.pdf
Polish 49.4 KB
2024-04-22 12:22
Major Shareholding Notification
Zmiana stanu posiadania - Content (PL)
Polish 562 bytes
2024-04-15 09:35
Legal Proceedings Report
Złożenie wniosku na import surowca farmaceutycznego przez spółkę stowarzyszoną …
Polish 1.4 KB
2024-03-28 08:33
M&A Activity
Zwrot pożyczonych akcji Cannabis Poland S.A. - Content (PL)
Polish 761 bytes
2024-03-20 21:48
Share Issue/Capital Change
Podwyższenie kapitału zakładowego spółki zależnej w wyniku nowej emisji akcji -…
Polish 707 bytes
2024-02-22 11:36
Share Issue/Capital Change
Zawarcie umowy inwestycyjnej w związku z istotnym dokapitalizowaniem spółki Hem…
Polish 2.4 KB
2024-02-21 12:29
M&A Activity
Podpisanie Term Sheet dotyczącego nabycia plantacji marihuany medycznej przez H…
Polish 1.9 KB
2024-02-12 13:16
Regulatory News Service
Podpisanie Term Sheet z portugalskim zakładem farmaceutycznym przez spółkę stow…
Polish 2.3 KB
2024-02-09 11:35
Regulatory News Service
Otrzymanie zezwolenia na prowadzenie obrotu hurtowego środkami odurzającymi ora…
Polish 1.4 KB
2024-01-22 08:42
M&A Activity
Zawarcie listu intencyjnego dotyczącego przeprowadzenia negocjacji dotyczących …
Polish 1.3 KB
2024-01-15 16:20
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Walnym Zgroma…
Polish 934 bytes
2023-12-19 16:35
Proxy Solicitation & Information Statement
zal03_H_H-NWZ-15.01.24-formularz_pelnomocnictwa.pdf
Polish 164.4 KB

Automate Your Workflow. Get a real-time feed of all Hemp Health Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Hemp Health Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ChoA Pharmaceutical Co., LTD. Logo
Global manufacturer of OTC medicines and health supplements distributed through pharmacies.
South Korea 034940
CHUGAI PHARMACEUTICAL CO., LTD. Logo
An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.
Japan 4519
Cinclus Pharma Holding AB Logo
Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.
Sweden CINPHA
Circio Holding ASA Logo
Developing circular RNA vector tech and immunotherapies for gene and cell therapies.
Norway CRNA
CJ Bioscience Logo
Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.
South Korea 311690
CKD Bio Corp. Logo
Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.
South Korea 063160
CMG Pharmaceutical Co., Ltd. Logo
Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.
South Korea 058820
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany CNW
Compugen Ltd. Logo
Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.
Israel CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies & provides preclinical CRO services to pharma & biotech.
South Korea 166480

Talk to a Data Expert

Have a question? We'll get back to you promptly.